Assessment of IV-to-PO conversion guideline implementation in pediatric cancer and bone marrow transplant patients after line removal for bloodstream infection.

Abstract

We assessed implementation of a local intravenous-to-enteral antimicrobial transition protocol for pediatric hematology/oncology and bone marrow transplant patients with bacterial or candidal bloodstream infection and central line removal. Among 76 cases, 57 met protocol criteria. Enteral antimicrobials were used in 29 (50.8%) cases meeting eligibility criteria for conversion.